Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
NCT00272558Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2004
- Primary completion
- Sep 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of carboplatin and vinorelbine in malignant pleural mesothelioma (MPM), sponsored by Rigshospitalet. Primary endpoint: Objective Response Rate. Started Sep 2004; status: completed.
02
Drugs
carboplatinvinorelbine
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00272558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00272558.